Clinical Trial Update: Stem Cell Injection to Treat Heart Damage During Open Heart Surgery [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating stem cell injections to treat heart damage during open-heart surgery has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Heart Disease
• Ischemic Heart Disease

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Heart Disease, Ischemic Heart Disease | Phase 1 | Status: TERMINATED